Ayvakyt : Orphan maintenance assessment report (post authorisation) (II-23)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
orphan-maintenance-report-post
medication.label.permit_number
EMA/OD/0000127063
medication.label.permit_validity
First published: 2024-02-06T13:29:51Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live